Deixe um recado
Ligaremos para você em breve!
Por favor verifique seu email!
Por favor verifique seu email!
Mais informações facilitam uma melhor comunicação.
Submetido com sucesso!
Ligaremos para você em breve!
Deixe um recado
Ligaremos para você em breve!
Por favor verifique seu email!
Por favor verifique seu email!
—— SIMPOR PHARMA
—— Nasir
—— IATEC, Argentina
—— Mohammed Saad
HEPA filters achieve ≥99.97% efficiency for particles ≥0.3μm, while ULPA filters offer superior performance with ≥99.9995% efficiency for particles ≥0.1μm. This makes ULPA ideal for ISO Class 3 environments (e.g., semiconductor fabrication), whereas HEPA suffices for ISO Class 5 zones (e.g., pharmaceutical cleanrooms). ULPA's enhanced capture of submicron particles (e.g., viruses like SARS-CoV-2 at 60–140nm) provides critical protection in high-risk areas like BSL-4 labs.
HEPA filters typically exhibit lower initial resistance (150–250Pa) compared to ULPA (100–250Pa), reducing energy consumption in HVAC systems. However, ULPA's extended lifespan (up to 24 months vs. HEPA's 12–18 months) offsets higher upfront costs. Studies show ULPA's mini-pleated designs can lower pressure drop by 10Pa, saving ~113kWh annually per filter at 3,400m³/h airflow.
HEPA filters are standard in ICU and surgery rooms (H13–H14 grades), while ULPA is mandatory for BSL-4 labs and semiconductor "cleanroom islands." Case studies reveal dual-stage HEPA (H13+H14) achieves ISO Class 5 in hospitals, whereas ULPA+Ag⁺ filters (e.g., JV-BioFilter) are deployed in Wuhan P4 Lab for viral containment. Modular cleanrooms often combine both: HEPA for general zones and ULPA for critical workflows.

